Clinical Cardiology 901 - Clinical Cardiology Alert - Jan 01, 2005

Target Audience:

This activity is intended for the cardiologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Michael H. Crawford, MD
Professor of Medicine
Chief of Clinical Cardiology
University of California
San Francisco

Editorial Board Members
John P. DiMarco, MD, PhD
Professor of Medicine
Division of Cardiology
University of Virginia
Charlottesville

Jonathan Abrams, MD
Professor of Medicine
Division of Cardiology
University of New Mexico
Albuquerque

Subjects:

  • Prophylactic Use of An ICD After Acute Myocardial Infarction
  • Antiplatelet or Anticoagulant Therapy in Atrial Fibrillation
  • Coronary Revascularization Before Vascular Surgery
  • Statin Metabolism Interactions
  • Nifedipine For Chronic Stable Angina
  • Atenolol For Hypertension

Objectives:

  • Present the latest information regarding diagnosis and treatment of cardiac disease, including new drug therapies, surgery, and other interventions
  • Discuss the pros and cons of these interventions, as well as possible complications
  • Discuss the pros and cons and cost-effectiveness of new and traditional diagnostic tests
  • Present current data regarding outpatient care of cardiac patients

Financial Disclosure:

In order to reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Jonathan Abrams, MDs serves on the speaker’s bureau for Merck, Pfizer, and Parke-Davis. John P. DiMarco, MD, PhD is a consultant for Bayer and Novartis, is on the speaker’s bureau for Medtronic and Guidant, and does research for Medtronic and Guidant. Michael H. Crawford, MD reports no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study.

Copyright 2005 AHC Media. All rights reserved.